Advertisement
Advertisement

CVKD

CVKD logo

Cadrenal Therapeutics, Inc. Common Stock

1.94
USD
Sponsored
-0.01
-0.51%
Aug 10, 15:58 UTC -4
Closed
exchange

After-Market

1.96

+0.02
+1.08%

Cadrenal Therapeutics, Inc. Common Stock Profile

About

Cadrenal Therapeutics Inc. is a biopharmaceutical company. It focused on developing tecarfarin, a clinical-stage novel cardiorenal therapy with orphan drug designation for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. Cadrenal Therapeutics Inc. is based in PONTE VEDRA, Fla.

Info & Links

CEO

Quang X. Pham

Headquarters

822 A1A North, Suite 306
Ponte Vedra, FL 32082, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.cadrenal.com

Auditor

WithumSmith+Brown, PC

Share holders

17

Employees

5

Cadrenal Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

7M

Enterprise Value

4.69M

Enterprise Value/EBITDA(ttm)

-0.39

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.34

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-411.03%

Return on Invested Capital(ttm)

-433.39%

Return on Assets(ttm)

-275.61%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-12.05M

Net Income Available to Common(ttm)

-11.89M

Diluted EPS(ttm)

-5.63

Share Statistics

Beta (5Y Monthly)

1.84

52-Week Change

-82.60%

S&P 500 52-Week Change

21.65%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

2.87M

Dividend Yield

0.00%

Float4

2.92M

% Held by Insiders

14.59%

% Held by Institutions

7.92%

Balance Sheet

Total Cash(mrq)

2.31M

Total Cash Per Share(mrq)

0.80

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.68%

Quick Ratio(mrq)

2.68%

Book Value Per Share(mrq)

0.72

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.25

Free Cash Flow(ytd)

-3.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement